TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of ...
SAN DIEGO--(BUSINESS WIRE)--CB Therapeutics, Inc. has achieved the first successful biosynthesis of DMT (N,N Dimethyltryptamine) and related tryptamine-based compounds in yeast and has filed a patent ...
CANTON, Ohio — A raid conducted by multiple local and federal investigators in Canton resulted in the seizure of approximately 10 kilograms of the hallucinogenic drug Dimethyltryptamine, better known ...
“This achievement marks a new major step in our objective to upgrade the development and production of our own Active Pharmaceutical Ingredients. This method can be scalable to potentially reach an ...